News, 10 June 2003
The Human Fertilisation and Embryology Authority has granted The Roslin
Institute a licence to carry out human parthenogenesis. The process
involves prompting unfertilised eggs to begin dividing, in effect
generating embryos without fertilisation. Parthenogenesis would not
necessarily generate a 'clone' of the mother, although the Roslin
Institute has expressed an interest in developing human clones. In
spite of assurances from the HFEA that embryo research would be
carefully regulated, the technique has been criticised from a number of
quarters. Archbishop Mario Conti, a fellow of the Royal Society of
Edinburgh, has accused the Roslin Institute of concealing from the
public the true nature of its research, whilst Dr John Fleming of the
Southern Cross Bioethics Institute commented: 'an embryonic human being
is still an embryonic human being. Where there is doubt the embryo must
be treated as a human being. The suggestion that this process bypasses
difficult ethical issues where the destruction of embryos is concerned
is not true.' [
BBC News, The Telegraph, The Herald, 10 June, SPUC source]
4 in 5 babies born with heart defects now survive, compared with 1 in 5
forty years ago, The Times reports. Only twenty years, a baby born with
a major heart defect had little chance of surviving as far as
adolescence, but with vastly improved diagnosis and surgical treatment,
it is now possible for women with heart problems to have children of
their own. The Times report focuses on the case of a
twenty-six-year-old woman who gave birth to a healthy baby shortly
after having heart valve surgery, thanks to the pioneering work of the
High Risk Cardiac Obstetric clinic linked with the Great Ormond Street
Hospital. However, many heart patients are unaware of the specialist
help available during pregnancy or are wrongly advised against having
children on health grounds. The British Heart Foundation is calling for
more specialist services to be established nation-wide. [
The Times, 10 June]
Health Canada has given initial approval to over-the-counter sales of
the Morning After Pill, following an application by distributors in
March last year. The Canadian Pharmacists Association and the Society
of Obstetricians and Gynaecologists of Canada collaborated on the
submission. The government will now request public feedback on the
subject before changing the drug's status. Campaign Life Coalition has
urged Health Canada to reject the change, as the pill 'acts upon the
uterine lining to make it hostile to the implantation of the human
embryo. This would be analogous to leaving a newborn baby alone in the
desert and is clearly an abortifacient action.' [
Canada LifeSite, 9 June]
Researchers at Harvard Medical School have discovered a protein that
prevents alcohol from interfering with neuron activity during brain
development, according to a report in New Scientist. It is hoped that
this could pave the way for a drug to protect unborn babies from
maternal alcohol abuse. Fetal Alcohol Syndrome currently affects up to
3 babies in every 1000 births in the United States and is the biggest
preventable cause of mental impairment in American children. Mary
Velasquez, a behavioural researcher at the University of Texas-Houston
Sciences Center, said that a drug would be welcome but expressed
concern about leaving women free to continue drinking throughout
pregnancy because of the other social and health-related problems
caused by excessive alcohol consumption. Alcohol Concern in the UK
stresses that the consumption of 1 or 2 units once or twice weekly is
unlikely to cause harm but recent studies have reported that even light
drinking may be detrimental to foetal development. [
New Scientist, 10 June]
To subscribe to SPUC's email information services, please visit www.spuc.org.uk/em-signup. The reliability of the news herein is dependent on that of the cited sources, which are paraphrased rather than quoted. Opinions expressed are not necessarily those of the society. © Society for the Protection of Unborn Children, 2012